Bill > S2022

This bill aims to enhance substance use prevention and treatment by implementing several key provisions. It mandates training for law enforcement officers on responding to drug-related overdoses and the application of relevant laws, and requires the state to collect and share resources on these topics. The bill also directs the establishment of a list of non-opioid pain management alternatives approved by the FDA, which will be distributed to healthcare providers. Furthermore, it introduces a module on addiction science into driver education courses and allows for verbal substance use disorder screenings in schools, with provisions for confidentiality and parental opt-out. The bill also defines "extended-release long-acting opioid in a non-abuse deterrent form" and introduces new requirements for prescribers, including evaluating patient risk factors, using the prescription drug monitoring program, and entering into pain management agreements for certain opioid prescriptions. A voluntary non-opiate directive form will be established, allowing individuals to refuse opiate prescriptions, and prescribers will be required to discuss prescription quantities and risks with patients before issuing opioid prescriptions. The bill also establishes a drug stewardship program requiring manufacturers to manage the collection, disposal, and safe disposal of unwanted drugs, and creates a Prescription Drug Awareness Trust Fund for public and professional education on prescription drug abuse. Additionally, it mandates informed consent from parents or guardians before prescribing opioids to minors, provides liability protection for those administering naloxone (an opioid overdose reversal medication), and establishes a rehabilitation program for pharmacists with substance use issues. The bill also prohibits the sale of powdered alcohol and requires insurance plans to cover pain management alternatives and implement safeguards for potentially addictive opioid prescriptions. Finally, it mandates reporting on mental health and substance use disorder claim denials, strengthens parity requirements for these services, and establishes various commissions and studies to further address pain management, addiction treatment, and impaired driving.